FORMYCON AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.95 EUR | +0.63% |
|
+3.36% | -29.17% |
| 25/04 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 18/03 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 43.20 | 49.60 | 52.20 |
| Spread/Res. | -7.52% | -19.46% | -23.47% |
| Spread/Supp. | +4.58% | +4.58% | +3.36% |
| Support | 38.20 | 38.20 | 38.65 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- FYB Stock
- Charts Formycon AG
